未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trials 伊沙妥昔单抗单药治疗复发或难治性多发性骨髓瘤的疗效与安全性：一项临床研究的合并分析 Dimopoulos, Meletios; Sunami, Kazutaka; Leleu, Xavier; Vij, Ravi; Gasparetto, Cristina; Suzuki, Kenshi; Mace, Sandrine; Tada, Keisuke; Hirakawa, Mutsumi; Iida, Shinsuke 分享 收藏
分享 收藏
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study Luskin, Marlise R.; Yin, Jun; Lozanski, Gerard; Curran, Emily; Malnassy, Gregory; Mrozek, Krzysztof; Bloomfield, Clara D.; Cataland, Spero R.; Fulton, Noreen; Kolitz, Jonathan; Laplant, Betsy; Kour, Oudom; Powell, Bayard L.; Vij, Ravi; Wang, Eunice S.; Grinblatt, David; Stone, Richard M.; Uy, Geoffrey L.; Larson, Richard A.; Stock, Wendy 分享 收藏
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma Zhou, Alice Y.; Marin, Nancy D.; Afrin, Sadia; Wong, Pamela; Tran, Jennifer; Jacobs, Miriam T.; Becker-Hapak, Michelle; Marsala, Lynne; Foster, Mark; Foltz, Jennifer A.; Neal, Carly C.; Russler-Germain, David A.; Morina, Lyra; Paik, Yeeun; Cubitt, Celia C.; Schappe, Timothy; Pence, Patrick; McClain, Ethan; Kelley, Sarah; Fortier, Julie; Fiala, Mark; Slade, Michael; Schroeder, Mark; Stockerl-Goldstein, Keith; Vij, Ravi; Gao, Feng; Berrien-Elliott, Melissa M.; Fehniger, Todd A. 分享 收藏
分享 收藏
Feasibility and Implementation of the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections ASH Research Collaborative关于浆细胞瘤患者COVID-19结局及疫苗影响（COSMIC）的可行性研究与实施：一项针对多发性骨髓瘤患者、用于监测与COVID-19疫苗及感染相关结局的去中心化、真实世界证据研究 Wood, William A.; Semmel, Emily A.; James, Shandra; Neuberg, Donna S.; Hewitt, Kathleen; Anderson, Kenneth C.; Kumar, Shaji; Schroeder, Mark A.; Chung, David J.; Rosenberg, Aaron S.; Zonder, Jeffrey A.; Rubinstein, Samuel M.; D'Souza, Anita; Martin, Thomas; Chari, Ajai; Vij, Ravi; Nooka, Ajay K.; Weiss, Brendan M.; Pederson, Levi D.; Derkach, Andriy; Geyer, Susan M.; Usmani, Saad Z. 分享 收藏
Idecabtagene Vicleucel (Ide-cel) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Front-Line Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up Idecabtagene Vicleucel (Ide-cel) 在对新诊断多发性骨髓瘤（NDMM）且对一线自体干细胞移植（ASCT）反应不足的患者（Pts）中的研究：KarMMa-2研究队列2c的扩展随访 Paul, Barry; Dhodapkar, Madhav V.; Alsina, Melissa; Berdeja, Jesus G.; Richard, Shambavi; Vij, Ravi; Leleu, Xavier; Egan, Daniel N.; Bergsagel, P. Leif; Reshef, Ran; Usmani, Saad Z.; Truppel-Hartmann, Anna; Basudhar, Debashree; Thompson, Ethan G.; Wu, Fan; Eliason, Laurie; Park, Soyun; Tran, Sinhan; Chaudhry, Maria; Siegel, David S.; Patel, Krina K. 分享 收藏
Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial 白血病相关突变（LAMs）在诱导治疗后清除与中危急性髓系白血病的不良预后相关：一项多中心、前瞻性II期试验的 interim 结果 Jacoby, Meagan; Spencer, David H.; Uy, Geoffrey L.; Gao, Feng; Burton, Tasha; Heath, Sharon E.; Du, Feiyu; O'Laughlin, Shelly; Fulton, Robert; Al-Mansour, Zeina A.; Cogle, Christopher R.; Huselton, Eric J.; Dipersio, John F.; Westervelt, Peter; Schroeder, Mark A.; Ghobadi, Armin; Pusic, Iskra; Stockerl-Goldstein, Keith; Kahl, Brad S.; Cashen, Amanda F.; Christopher, Matt; Singh, Nathan; Vij, Ravi; Crees, Zachary D.; Day, Ryan B.; Fehniger, Todd; Oetjen, Karolyn; Patel, Dilan A.; Kim, Miriam Y.; Slade, Michael; Link, Daniel C.; Walter, Matthew J.; Abboud, Camille N.; Abboud, Ramzi; Ley, Timothy J. 分享 收藏
Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States Hultcrantz, Malin; Kleinman, David; Vij, Ravi; Escalante, Fernando; Delforge, Michel; Kotowsky, Nirali; Bitetti, Jacopo; Boytsov, Natalie; Camadoo-O'Byrne, Leena; Happ, Lindsey Powers; Germain, Guillaume; Urosevic, Ana; Mahendran, Malena; Duh, Mei Sheng; Laliberte, Francois; Cavo, Michele; Lee, Hans C. 分享 收藏
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma isatuximab，苯达莫司汀和泼尼松在复发/难治性多发性骨髓瘤中的Ib期试验 Goldsmith, Scott R.; Slade, Michael J.; Fiala, Mark; Harding, Melinda; Crees, Zachary D.; Schroeder, Mark A.; Stockerl-Goldstein, Keith; Vij, Ravi 分享 收藏
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma Sun, Jennifer; Corradini, Stefan; Azab, Feda; Shokeen, Monica; Muz, Barbara; Miari, Katerina E.; Maksimos, Mina; Diedrich, Camila; Asare, Obed; Alhallak, Kinan; Park, Chaelee; Lubben, Berit; Chen, Yixuan; Adebayo, Ola; Bash, Hannah; Kelley, Sarah; Fiala, Mark; Bender, Diane E.; Zhou, Haibin; Wang, Shaomeng; Vij, Ravi; Williams, Mark T. S.; Azab, Abdel Kareem 分享 收藏
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial Richard, Shambavi; Lesokhin, Alexander M.; Paul, Barry; Kaufman, Jonathan L.; Pianko, Matthew; Biran, Noa; Vij, Ravi; Doxie, Deon B.; Azeem, Maryam I.; Martillo, Mercedes; Wozniak, Katie; Cho, Hearn J.; Dhodapkar, Kavita M.; Dhodapkar, Madhav V. 分享 收藏
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes 多发性骨髓瘤的综合分子谱分析可确定精细的拷贝数和表达亚型 Skerget, Sheri; Penaherrera, Daniel; Chari, Ajai; Jagannath, Sundar; Siegel, David S.; Vij, Ravi; Orloff, Gregory; Jakubowiak, Andrzej; Niesvizky, Ruben; Liles, Darla; Berdeja, Jesus; Levy, Moshe; Wolf, Jeffrey; Usmani, Saad Z.; Christofferson, Austin W.; Nasser, Sara; Aldrich, Jessica L.; Legendre, Christophe; Benard, Brooks; Miller, Chase; Turner, Bryce; Kurdoglu, Ahmet; Washington, Megan; Yellapantula, Venkata; Adkins, Jonathan R.; Cuyugan, Lori; Boateng, Martin; Helland, Adrienne; Kyman, Shari; McDonald, Jackie; Reiman, Rebecca; Stephenson, Kristi; Tassone, Erica; Blanski, Alex; Livermore, Brianne; Kirchhoff, Meghan; Rohrer, Daniel C.; D'Agostino, Mattia; Gamella, Manuela; Collison, Kimberly; Stumph, Jennifer; Kidd, Pam; Donnelly, Andrea; Zaugg, Barbara; Toone, Maureen; McBride, Kyle; DeRome, Mary; Rogers, Jennifer; Craig, David; Liang, Winnie S.; Gutierrez, Norma C.; Jewell, Scott D.; Carpten, John; Anderson, Kenneth C.; Cho, Hearn Jay; Auclair, Daniel; Lonial, Sagar; Keats, Jonathan J. 分享 收藏
Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma Rodriguez-Otero, Paula; Ailawadhi, Sikander; Arnulf, Bertrand; Patel, Krina; Cavo, Michele; Nooka, Ajay K.; Manier, Salomon; Callander, Natalie; Costa, Luciano J.; Vij, Ravi; Bahlis, Nizar J.; Moreau, Philippe; Solomon, Scott R.; Delforge, Michel; Berdeja, Jesus; Truppel-Hartmann, Anna; Yang, Zhihong; Favre-Kontula, Linda; Wu, Fan; Piasecki, Julia; Cook, Mark; Giralt, Sergio 分享 收藏
分享 收藏
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial Slade, Michael; Fiala, Mark A.; Kirchmeyer, Marie; King, Jeff; Gao, Feng; Schroeder, Mark A.; Stewart, A. Keith; Stockerl-Goldstein, Keith; Chen, Christine; Vij, Ravi 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
.png){kind=icon}
分享.png){kind=icon}
收藏